FLAVIO PATERNO, MD

NEWARK, NJ

Research Active
Surgery NPI registered 19+ years 42 publications 2003 – 2026 NPI: 1760666507

Practice Location

140 BERGEN ST
NEWARK, NJ 07103-2425

Phone: (973) 972-7218

What does FLAVIO PATERNO research?

Flavio Paterno studies various aspects of organ transplantation, specifically liver and kidney transplants. His research includes creating new ways to predict survival after liver transplants by analyzing blood markers and looking at social media discussions about organ transplants. He also examines how different methods of organ preservation can affect the success of these surgeries. Additionally, Paterno investigates the outcomes of transplants for uninsured patients and how financial assistance programs can improve transplant eligibility and care.

Key findings

  • His study found that high-risk liver transplant patients had a 63.6% mortality rate within one year, compared to only 1.9% for low-risk patients using a new biomarker tool.
  • Patients receiving liver transplants through a state assistance program had a one-year survival rate of about 93%, similar to those with private or government insurance.
  • Using a portable hypothermic oxygenated machine for liver preservation reduced early liver dysfunction to 11.1%, compared to 16.4% with standard cold storage.
  • In redo liver transplants, 34% of cases met favorable outcome criteria, resulting in a one-year survival rate of 90%, despite complications affecting 76% of patients post-surgery.
  • Transplanting kidneys infected with hepatitis C into HCV-infected recipients proved to be cost-effective, saving approximately $41,591 per patient compared to using uninfected kidneys.

Frequently asked questions

Does Dr. Paterno study liver transplants?
Yes, he focuses on various aspects of liver transplantation, including patient outcomes and new preservation methods.
What kind of support does Dr. Paterno research for uninsured transplant patients?
He studies how state assistance programs can provide uninsured patients with access to liver transplants and improve their outcomes.
Is Dr. Paterno's work relevant for kidney transplant patients?
Absolutely, he has researched kidney transplantation practices, including the impact of donor health and infection status on patient outcomes.
What new methods has Dr. Paterno developed for predicting transplant success?
He has developed biomarker panels and indices that better assess the risk of mortality after liver transplants, offering more accurate predictions than traditional methods.
How does Dr. Paterno address issues related to organ preservation during transplants?
His research includes innovative techniques like hypothermic oxygenated machine perfusion, which significantly improve organ quality before transplantation.

Publications in plain English

Development and Internal Validation of a Pretransplant Biomarker Panel for Mortality Prediction Following Liver Transplant.

2026

JAMA surgery

Panayotova GG, Simonishvili S, Jin L, Nguyen DT, Graviss EA +18 more

Plain English
Researchers studied how to better predict the survival of patients after they receive a liver transplant by developing a new system called the Liver Immune Frailty Index (LIFI). They found that patients with higher levels of certain biomarkers in their blood before the transplant had a much higher risk of dying within a year: 1.9% for low risk, 10.3% for moderate risk, and 63.6% for high risk. This matters because LIFI can help doctors choose the right candidates for liver transplants and improve patient care, ultimately saving lives.

PubMed

Consulting r/Transplant: Assessment of Reddit Use and Sentiment in Solid Organ Transplantation.

2026

Transplantation direct

Herzog A, Goyal D, Paterno F, Amin A, Guarrera JV +2 more

Plain English
This study looked at how people in the transplant community use Reddit to share their experiences and information about solid organ transplants, like kidney and liver surgeries. Researchers analyzed 1,000 posts and found that most were positive, with 66.5% coming from transplant recipients and discussing life after surgery. These findings highlight that Reddit is a valuable resource for support and information exchange, which could inform improvements in healthcare for transplant patients.

PubMed

Acceptable outcomes of liver transplantation in uninsured patients under the coverage of a state assistance program.

2025

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Paterno F, Lee-Riddle GS, Olivo R, Amin AN, Koneru B +3 more

Plain English
This study examined outcomes from 60 uninsured liver transplant patients whose procedures were covered by a state charity care program, comparing them to insured patients transplanted at the same center over 18 years. Survival rates at one and three years were statistically identical across uninsured, privately insured, and government-insured groups, with no differences in graft survival, hospital stay length, or readmission rates. The results demonstrate that with adequate financial support, uninsured patients can achieve transplant outcomes equal to insured patients.

PubMed

Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation: A randomized, open-label, clinical trial.

2024

Hepatology (Baltimore, Md.)

Panayotova GG, Lunsford KE, Quillin RC, Rana A, Agopian VG +13 more

Plain English
Livers stored on ice before transplant suffer ischemia damage that worsens outcomes. This randomized trial tested a portable device that keeps the liver oxygenated and perfused during transport, compared to standard cold storage. The results support that hypothermic oxygenated machine perfusion reduces injury and could become a new standard for liver preservation in the U.S.

PubMed

Pre-transplant Biomarkers of Immune Dysfunction Improve Risk Assessment of Post-transplant Mortality Compared to Conventional Clinical Risk Scores.

2023

Research square

Medina-Morales JE, Panayotova GG, Nguyen DT, Graviss EA, Prakash GS +14 more

Plain English
Researchers studied how well a new tool called the Liver Immune Frailty Index (LIFI) predicts the risk of death after a liver transplant, comparing it to older methods. They found that patients with a low LIFI score had only a 1.4% chance of dying within a year of the transplant, while those with a high score had a 58.3% chance. This new approach is important because it offers a more accurate way to identify candidates who are most likely to survive after the surgery, potentially saving lives by better selecting who should receive a transplant.

PubMed

Marginal Costotomy: A Novel Surgical Technique to Rescue from "Large-for-Size Syndrome" in Liver Transplantation.

2022

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Paterno F, Amin A, Lunsford KE, Brown LG, Pyrsopoulos N +2 more

PubMed

Novel Benchmark Values for Redo Liver Transplantation: Does the Outcome Justify the Effort?

2022

Annals of surgery

Abbassi F, Gero D, Muller X, Bueno A, Figiel W +47 more

Plain English
This study looked at the outcomes of redo liver transplants, which are surgeries performed on patients who have had a previous liver transplant that failed. Among 1,110 redo transplants analyzed, 34% met specific criteria for what the researchers considered "benchmark cases," where the outcomes were more favorable. For these benchmark cases, the one-year survival rate was 90%, but complications were common, with 76% experiencing issues after surgery, increasing to 87% by one year. This research provides a clearer picture of what to expect from redo liver transplants and can help guide decisions about how to use limited organ resources effectively.

PubMed

Is liver transplantation a viable option for the treatment of intrahepatic cholangiocarcinoma?

2021

Journal of surgical oncology

Prakash GS, Amin A, Paterno F, Brown LG, Guarrera JV +1 more

PubMed

Expanding indications for liver transplantation in the era of liver transplant oncology.

2021

World journal of gastrointestinal surgery

Panayotova G, Lunsford KE, Latt NL, Paterno F, Guarrera JV +1 more

Plain English
This study looked at how liver transplantation can be used more widely for patients with certain types of cancer, particularly focusing on how cancer treatment responses and tumor characteristics can affect patient outcomes. Researchers found that liver transplant patients with stable cancer before their surgery tend to have better survival rates. This is important because it shows that by improving how we evaluate and treat cancer patients, we might be able to safely increase the number of liver transplants performed for those with advanced cancers, leading to better overall health outcomes.

PubMed

Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection.

2020

Transplantation

Lichvar AB, Tremblay S, Leino AD, Shields AR, Cardi MA +10 more

Plain English
This study looked at kidney transplant patients who experienced different types of rejection after their transplant and how reducing specific antibodies in their blood affected their long-term kidney survival. Among 108 patients, those who had a significant drop (more than 50%) in these specific antibodies within 14 days had better kidney survival rates three years later: 88.3% for early acute rejection compared to only 54.9% for late mixed acute rejection. This is important because it shows that timely treatment to lower these antibodies can lead to better long-term outcomes for kidney transplant recipients.

PubMed

A Case Report of Alloimmune Hepatitis after Direct-acting Antiviral Treatment in a Liver Transplant Patient.

2020

Journal of clinical and translational hepatology

Choi C, Botros Y, Shah J, Xue P, Jones A +6 more

Plain English
A woman who received a liver transplant for hepatitis C developed a rare liver condition called alloimmune hepatitis after starting a new treatment for her recurring infection with the virus. This condition appeared about two weeks after she began taking specific antiviral medications. This finding highlights a potential risk for liver transplant patients who are treated with these drugs, as their immune systems might react unexpectedly after the infection is cleared.

PubMed

Novel Arterial Reconstruction With Donor Femoral Artery in Split-Liver Transplantation.

2020

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Paterno F, Brown L, Wilson D, Pyrsopoulos N, Guarrera JV

PubMed

Liver Transplantation Beyond Milan Criteria.

2020

Journal of clinical and translational hepatology

Lingiah VA, Niazi M, Olivo R, Paterno F, Guarrera JV +1 more

Plain English
This study looked at liver transplantation options for patients with liver cancer (HCC) that don't meet the standard size limits known as the Milan criteria. The researchers found that patients whose cancer exceeds these limits can still be helped through treatments that shrink tumors, which makes them eligible for transplants. This is important because it means more patients may get lifesaving transplants, potentially improving survival rates from liver cancer.

PubMed

Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications.

2020

Current oncology reports

Panayotova GG, Paterno F, Guarrera JV, Lunsford KE

Plain English
This study looked at the use of liver transplants for a rare cancer called cholangiocarcinoma, particularly when the cancer can't be surgically removed. The researchers found that while liver transplants are currently allowed for early stages of the disease near the liver, they are showing positive results for patients with localized tumors further inside the liver. This is important because it could offer more patients a chance for longer survival and better treatment options, but careful planning is needed to ensure the limited number of donor organs are used wisely.

PubMed

Novel oxygenation technique for hypothermic machine perfusion of liver grafts: Validation in porcine Donation after Cardiac Death (DCD) liver model.

2020

American journal of surgery

Panayotova GG, Rosado J, Paterno F, Deo D, Dikdan G +8 more

Plain English
Researchers studied a new way to supply oxygen to liver grafts during transport to improve transplant outcomes. They found that using a portable pump with a "pre-charge" of oxygen led to better results compared to traditional methods, with significant reductions in liver cell damage markers such as ALT and LDH. This new technique is important because it could make it easier to transport liver organs safely, ultimately leading to better transplant success rates.

PubMed

High density is a property of slow-cycling and treatment-resistant human glioblastoma cells.

2019

Experimental cell research

Sabelström H, Quigley DA, Fenster T, Foster DJ, Fuchshuber CAM +9 more

Plain English
Researchers studied a specific type of brain tumor cells in glioblastoma, focusing on those that grow slowly and resist treatment. They found that these slow-cycling cells are denser and bigger than other tumor cells, and they are better at surviving aggressive therapies like radiation and chemotherapy. This matters because understanding these resilient cells could lead to more effective treatments and help prevent the recurrence of this deadly disease.

PubMed

Clinical Implications of Donor Warm and Cold Ischemia Time in Donor After Circulatory Death Liver Transplantation.

2019

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Paterno F, Guarrera JV, Wima K, Diwan T, Cuffy MC +3 more

Plain English
This study looked at the effects of the time a donor liver spends warm before cooling (donor warm ischemia time or DWIT), the time a donor is in distress before death (donor agonal time or DAT), and the time the liver is stored cold before transplantation (cold ischemia time or CIT) on liver transplant outcomes. Researchers found that livers from donors with warm times of up to 40 minutes did just as well as those with shorter times, but if the cold storage time exceeded 4 hours, there was a higher risk of transplant failure and other complications. This matters because it shows that slightly longer warm times are manageable, but keeping cold storage under 4 hours is crucial for successful liver transplants.

PubMed

Cost of achieving equivalent outcomes in sicker patients after liver transplant.

2018

HPB : the official journal of the International Hepato Pancreato Biliary Association

Dhar VK, Wima K, Kim Y, Hoehn RS, Jung AD +4 more

Plain English
This study looked at the costs associated with liver transplants for patients who had a straightforward recovery. Researchers analyzed data from over 5,700 patients and found that those with higher treatment costs were more seriously ill and used more resources, such as lab tests and blood transfusions. Despite these higher costs, patients with greater severity of illness had the same two-year survival rates as those who spent less on treatment, showing that investing more in care for sicker patients can lead to similar long-term health outcomes.

PubMed

Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.

2018

Hepatology (Baltimore, Md.)

Bari K, Luckett K, Kaiser T, Diwan T, Cuffy M +9 more

Plain English
Researchers studied the risk of hepatitis C transmission from liver donors who tested positive for antibodies to the virus but had undetectable levels in their blood. They found that 16% of recipients who received livers from these donors contracted hepatitis C within 3 months, with all transmissions linked to donors who died from drug overdoses. This is important because, with effective treatments available, using livers from these donors could safely increase the number of available organs for transplant.

PubMed

Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis.

2018

Annals of internal medicine

Eckman MH, Woodle ES, Thakar CV, Paterno F, Sherman KE

Plain English
This study looked at whether it's more cost-effective to transplant kidneys infected with the hepatitis C virus (HCV) into patients who already have HCV, or to use uninfected kidneys. Researchers found that transplanting HCV-infected kidneys, followed by treatment for the virus, led to better outcomes and saved about $41,591 per patient compared to using uninfected kidneys, mainly because uninfected kidneys had longer wait times. This is important because it shows a more efficient way to handle kidney transplants for HCV-infected patients, improving their lives while also reducing healthcare costs.

PubMed

Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.

2018

Annals of internal medicine

Eckman MH, Woodle ES, Thakar CV, Paterno F, Sherman KE

PubMed

Evaluation of body weight and visual scores for genetic improvement of Nelore cattle.

2017

Tropical animal health and production

Paterno FM, Buzanskas ME, Koury Filho W, Lôbo RB, Queiroz SA

Plain English
Researchers studied the body weight and physical traits of Nelore cattle in Brazil to improve breeding practices. They found that traits like body structure, muscularity, and weight at specific ages are strongly influenced by genetics, with heritability estimates ranging from 0.28 to 0.50. This matters because using these traits as selection criteria can lead to better cattle performance and improved carcass quality in future generations.

PubMed

Use of Elderly Allografts in Liver Transplantation.

2016

Transplantation

Paterno F, Wima K, Hoehn RS, Cuffy MC, Diwan TS +3 more

Plain English
This study looked at using livers from donors aged 70 and older for liver transplants in the U.S. From 2007 to 2011, only 4.3% of liver donors were in this age group, and these livers were often given to healthier patients, leading to similar survival rates after surgery compared to younger donors. Although older donor livers had a higher risk of being rejected, the overall results highlight that using livers from elderly donors can be safe and beneficial for certain patients, especially as the demand for organs continues to rise.

PubMed

Hepatic Artery Pseudoaneurysm After Liver Transplantation.

2016

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Reznichenko AA, Bondoc A, Paterno F, Shah SA

PubMed

Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA Antibodies.

2016

Transplantation direct

Paterno F, Girnita A, Brailey P, Witte D, Wang J +9 more

Plain English
This study looked at the outcomes of patients receiving simultaneous liver and kidney transplants who had a high level of antibodies that could cause rejection. The researchers found that even though the liver didn't stop the immediate damage to the kidney, both organs eventually functioned well and stayed healthy after a year, as the harmful antibodies decreased over time. This matters because it shows that with careful management, it is possible for highly sensitized patients to successfully receive both a liver and kidney transplant, improving their chances for a better quality of life.

PubMed

Impact of recipient morbid obesity on outcomes after liver transplantation.

2015

Transplant international : official journal of the European Society for Organ Transplantation

Singhal A, Wilson GC, Wima K, Quillin RC, Cuffy M +7 more

Plain English
This study looked at the effects of severe obesity in patients receiving liver transplants. Out of over 12,000 patients, about 3% were severely obese and showed greater health issues before the transplant, such as being more likely to be female, diabetic, and having liver cirrhosis. Although these obese patients used more hospital resources and stayed longer after the surgery, their chances of surviving and the health of their transplanted liver were similar to those of non-obese patients in the two years following the transplant. This finding is important because it shows that while severely obese patients may require more care, they can still have the same success rates as others after the transplant.

PubMed

Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a national cohort study.

2015

Liver international : official journal of the International Association for the Study of the Liver

Hoehn RS, Singhal A, Wima K, Sutton JM, Paterno F +4 more

Plain English
This study examined how having diabetes before a liver transplant affects recovery and hospital costs. Among nearly 12,500 patients, those with diabetes spent more time in the hospital (10 days vs. 9 days), faced a higher risk of dying shortly after surgery (5% vs. 4%), and had higher rates of readmission within 30 days (41% vs. 37%). Understanding these differences is important because it highlights the need for tailored care and resources for diabetic patients undergoing liver transplants.

PubMed

Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy.

2015

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Freeman CM, Woodle ES, Shi J, Alexander JW, Leggett PL +9 more

Plain English
This study looked at how a surgical procedure called laparoscopic sleeve gastrectomy (LSG) can help severely obese people who need kidney transplants. Out of 52 patients, over half (55.8%) lost enough weight to be eligible for a transplant within about three months, and on average, they lost about 32% of their excess weight. This is important because the surgery not only helps patients lose weight but also significantly reduces their need for blood pressure and insulin medications, making them healthier candidates for a kidney transplant.

PubMed

Variation by center and economic burden of readmissions after liver transplantation.

2015

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Wilson GC, Hoehn RS, Ertel AE, Wima K, Quillin RC +4 more

Plain English
This study looked at hospital readmissions for patients who had a liver transplant in the U.S. and found that about 38% were readmitted within 30 days, with many returning within just a week after leaving the hospital. Factors like diabetes and how severe the liver disease was before the transplant increased the risk of readmission. This is important because readmissions not only reduce the chances of recovery but also lead to significantly higher costs—around $43,785 more compared to those who don’t get readmitted in the first 90 days.

PubMed

Hospital Resource Use with Donation after Cardiac Death Allografts in Liver Transplantation: A Matched Controlled Analysis from 2007 to 2011.

2015

Journal of the American College of Surgeons

Singhal A, Wima K, Hoehn RS, Quillin RC, Woodle ES +4 more

Plain English
Researchers studied liver transplants from organs donated after cardiac death (DCD) versus those from donors who passed away from brain death (DBD) between 2007 and 2011. They found that while both types of transplants seemed to have similar hospital stays and survival rates, DCD transplants had higher costs ($110,414 compared to $99,543) and increased likelihood of needing readmission within 30 days (46.4% for DCD versus 37.1% for DBD). This matters because it highlights the higher financial and resource demands of using DCD organs, despite them being linked to lower health scores in recipients and poorer long-term success compared to DBD transplants.

PubMed

Case Report: Hemolytic Anemia Following Deceased Donor Renal Transplantation Associated With Tranexamic Acid Administration for Disseminated Intravascular Coagulation.

2015

Transplantation proceedings

Revollo JY, Cuffy MC, Witte DP, Paterno F, Alloway RR +1 more

Plain English
This study looked at kidney transplants from donors who received a drug called tranexamic acid, which is used to prevent bleeding in patients with a serious condition. The researchers found that both kidney transplant recipients developed a rare type of anemia due to small blood clots in the transplanted kidneys. This is important because it raises concerns about using tranexamic acid in donors, as it may harm the recipients' kidneys after the transplant.

PubMed

Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous Immunoglobulin.

2015

Transplantation proceedings

Revollo JY, Cuffy MC, Abu Jawdeh BG, Paterno F, Girnita A +3 more

Plain English
This study focused on a patient with extremely high levels of antibodies that made it very difficult for them to receive a kidney transplant. By using a treatment called bortezomib instead of the usual methods, the patient was successfully desensitized and was able to receive a kidney from a living donor, resulting in a positive outcome. This approach offers hope for other highly sensitized patients who struggle to find suitable donors and may change how kidney transplants are handled in the future.

PubMed

Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis.

2014

HPB : the official journal of the International Hepato Pancreato Biliary Association

Wilson GC, Quillin RC, Wima K, Sutton JM, Hoehn RS +6 more

Plain English
This study looked at liver transplants for patients aged 70 and older compared to younger patients. Out of over 12,000 patients studied, those 70 and older had similar hospital stays, costs, and short-term survival rates after the transplant, but they experienced worse long-term survival. Despite the challenges, selected older patients can do just as well as younger patients in the short term, making it clear that age alone shouldn't rule them out for this lifesaving procedure.

PubMed

Hospital utilization and consequences of readmissions after liver transplantation.

2014

Surgery

Paterno F, Wilson GC, Wima K, Quillin RC, Abbott DE +5 more

Plain English
This study examined hospital readmissions among liver transplant patients over a year. It found that 69% of patients were readmitted within a year, averaging 2.7 times each, with 41% readmitted within the first 30 days—often due to infections or kidney problems. These readmissions are a serious issue because they lead to worse health outcomes for patients, highlighting the need for better care and prevention strategies after liver transplants.

PubMed

Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation.

2014

Surgery

Quillin RC, Wilson GC, Sutton JM, Hanseman DJ, Paterno F +6 more

Plain English
In Ohio, the number of liver transplants due to a liver disease called nonalcoholic steatohepatitis (NASH) rose significantly from 2000 to 2012, with more than a quarter of patients listed for transplant having this condition by the end of the study. Researchers found that patients with NASH had similar or better survival rates post-transplant compared to those with other liver diseases like hepatitis C or alcoholic liver disease. This is important because it shows that as obesity rates rise, organ transplants for fatty liver disease could lead to good outcomes, highlighting a need to pay more attention to this growing issue.

PubMed

Bortezomib for acute antibody-mediated rejection in liver transplantation.

2012

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Paterno F, Shiller M, Tillery G, O'Leary JG, Susskind B +2 more

Plain English
A study looked at three patients who experienced a rare but serious type of rejection after receiving liver transplants. All of them showed signs of severe rejection that didn't respond to standard treatments. After being treated with a drug called bortezomib, all three patients saw improvements in their liver function tests, and their rejection symptoms significantly decreased. This is important because it shows that bortezomib can effectively treat a tough condition that typically complicates post-transplant recovery.

PubMed

Metastatic Colon Cancer to the Thyroid Gland in the Setting of Pathologically Diagnosed Papillary Thyroid Cancer: A Review and Report of a Case.

2011

World journal of oncology

Starker LF, Paterno F, Bjorklund P, Wasson D, Atweh N

Plain English
This study looked at cases where colon cancer spreads to the thyroid gland, which is quite rare. It included a specific example where a person was unexpectedly found to have colon cancer after doctors examined their thyroid. Understanding this connection is important because it highlights the need for thorough examinations when dealing with thyroid issues, as it can uncover serious underlying conditions like colon cancer.

PubMed

Pseudointraductal papillary mucinous neoplasia caused by microscopic periductal endocrine tumors of the pancreas: a report of 3 cases.

2011

Human pathology

Kenney B, Singh G, Salem RR, Paterno F, Robert ME +1 more

Plain English
This study looked at three cases of pancreatic tumors that were initially thought to be a specific type called intraductal papillary mucinous neoplasms (IPMNs). However, after further examination, it was discovered that these tumors were actually small endocrine tumors that were pushing against the pancreatic duct, making them look like IPMNs. Understanding that these smaller tumors can mimic IPMNs is important to prevent misdiagnosis, which can impact treatment decisions.

PubMed

Malpositioned transjugular intrahepatic portosystemic shunt in the common hepatic duct leading to biliary obstruction and liver transplantation.

2011

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Paterno F, Khan A, Cavaness K, Asolati M, Campsen J +5 more

PubMed

Ischemic colitis: risk factors for eventual surgery.

2010

American journal of surgery

Paterno F, McGillicuddy EA, Schuster KM, Longo WE

Plain English
This study looked at patients with ischemic colitis, a condition where blood flow to the intestines is reduced, to determine which factors might indicate a need for surgery. Out of 253 patients, 48 required surgery at some point, with 12 needing it right away and 36 later. Key factors that suggested surgery might be necessary included having fluid in the abdomen seen on scans and not having active rectal bleeding, which could help doctors decide who needs urgent surgical intervention to prevent further health issues.

PubMed

The etiology and pathogenesis of vascular disorders of the intestine.

2008

Radiologic clinics of North America

Paterno F, Longo WE

Plain English
This research paper examined conditions where the blood supply to the intestines is insufficient, leading to various types of intestinal disorders. It found that common causes include hardening of the arteries and blood clots, and the severity of injury can range from minor to life-threatening. Understanding these causes and how they affect the intestines is important because diagnosing and treating these conditions remains difficult despite medical advancements.

PubMed

Tools for remote usability evaluation of Web applications through browser logs and task models.

2003

Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc

Paganelli L, Paternò F

Plain English
This study focused on developing a tool that analyzes browser logs to assess how people use websites compared to their intended design. The researchers created a method to compare user behavior data with the actual tasks a website is supposed to facilitate. This matters because it can help identify where users struggle or go off track, allowing for improvements in website usability without the high costs of video analysis.

PubMed

Frequent Co-Authors

James V Guarrera Shimul A Shah Keri E Lunsford E Steve Woodle Koffi Wima Daniel E Abbott Arpit Amin R Cutler Quillin Richard S Hoehn Guergana G Panayotova

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.